The U.S. Food and Drug Administration approved Johnson & Johnson’s drug Darzalex Faspro as the first treatment for adults with high-risk smoldering multiple myeloma, a precursor to the blood cancer.

Harbour BioMed, a global biopharmaceutical company, and Evinova, a global health-tech company, have entered a strategic ...

Argonaut Manufacturing Services, a contract development manufacturing organization (CDMO) specializing in aseptic drug product manufacturing and the manufacturing of life science and diagnostic ...

Cytiva has launched the fibro dT platform for mRNA capture and purification processes.

Abzena, an integrated CDMO for complex biologics and bioconjugates, and Mabqi, a biotechnology company focused on developing fully human antibodies, formed a strategic partnership.

Alvotech and Advanz Pharma Receive Marketing Authorizations for Gobivaz, a Biosimilar to Simponi (golimumab), from the MHRA.